Evidence map›Paper›PMID 27193196›Full record

ArticleJournal of neuroinflammation2016

Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.

R Marignier, A Ruiz, S Cavagna, A Nicole, C Watrin, M Touret, S Parrot, G Malleret, C Peyron, C Benetollo and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Neonatal Fc Receptor-Targeted Therapies in Neurology.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Review
  12. Article
  13. Treatment of Neuromyelitis Optica Spectrum Disorders.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

R MarignierINSERM U1028, CNRS UMR 5292, Center for Research in Neuroscience of Lyon, Lyon, France. romain.marignier@chu-lyon.fr.
A RuizINSERM U1028, CNRS UMR 5292, Center for Research in Neuroscience of Lyon, Lyon, France.
S CavagnaINSERM U1028, CNRS UMR 5292, Center for Research in Neuroscience of Lyon, Lyon, France.
A NicoleINSERM U1028, CNRS UMR 5292, Center for Research in Neuroscience of Lyon, Lyon, France.
C WatrinINSERM U1028, CNRS UMR 5292, Center for Research in Neuroscience of Lyon, Lyon, France.
M TouretINSERM U1028, CNRS UMR 5292, Center for Research in Neuroscience of Lyon, Lyon, France.
S ParrotINSERM U1028, CNRS UMR 5292, Center for Research in Neuroscience of Lyon, Lyon, France.
G MalleretINSERM U1028, CNRS UMR 5292, Center for Research in Neuroscience of Lyon, Lyon, France.
C PeyronINSERM U1028, CNRS UMR 5292, Center for Research in Neuroscience of Lyon, Lyon, France.
C BenetolloINSERM U1028, CNRS UMR 5292, Center for Research in Neuroscience of Lyon, Lyon, France.
N AuvergnonINSERM U1028, CNRS UMR 5292, Center for Research in Neuroscience of Lyon, Lyon, France.
S VukusicINSERM U1028, CNRS UMR 5292, Center for Research in Neuroscience of Lyon, Lyon, France.
P GiraudonINSERM U1028, CNRS UMR 5292, Center for Research in Neuroscience of Lyon, Lyon, France.
Centre National de la Recherche Scientifique · FRCentre de Recherche en Neurosciences de Lyon · FRInserm · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDevic's neuromyelitis optica (NMO) is an autoimmune astrocytopathy, associated with central nervous system inflammation, demyelination, and neuronal injury. Several studies confirmed that autoantibodies directed against aquaporin-4 (AQP4-IgG) are relevant in the pathogenesis of NMO, mainly through complement-dependent toxicity leading to astrocyte death. However, the effect of the autoantibody per se and the exact role of intrathecal AQP4-IgG are still controversial.

methodsTo explore the intrinsic effect of intrathecal AQP4-IgG, independent from additional inflammatory effector mechanisms, and to evaluate its clinical impact, we developed a new animal model, based on a prolonged infusion of purified immunoglobulins from NMO patient (IgG(AQP4+), NMO-rat) and healthy individual as control (Control-rat) in the cerebrospinal fluid (CSF) of live rats.

resultsWe showed that CSF infusion of purified immunoglobulins led to diffusion in the brain, spinal cord, and optic nerves, the targeted structures in NMO. This was associated with astrocyte alteration in NMO-rats characterized by loss of aquaporin-4 expression in the spinal cord and the optic nerves compared to the Control-rats (p = 0.001 and p = 0.02, respectively). In addition, glutamate uptake tested on vigil rats was dramatically reduced in NMO-rats (p = 0.001) suggesting that astrocytopathy occurred in response to AQP4-IgG diffusion. In parallel, myelin was altered, as shown by the decrease of myelin basic protein staining by up to 46 and 22 % in the gray and white matter of the NMO-rats spinal cord, respectively (p = 0.03). Loss of neurofilament positive axons in NMO-rats (p = 0.003) revealed alteration of axonal integrity. Then, we investigated the clinical consequences of such alterations on the motor behavior of the NMO-rats. In a rotarod test, NMO-rats performance was lower compared to the controls (p = 0.0182). AQP4 expression, and myelin and axonal integrity were preserved in AQP4-IgG-depleted condition. We did not find a major immune cell infiltration and microglial activation nor complement deposition in the central nervous system, in our model.

conclusionsWe establish a link between motor-deficit, NMO-like lesions and astrocytopathy mediated by intrathecal AQP4-IgG. Our study validates the concept of the intrinsic effect of autoantibody against surface antigens and offers a model for testing antibody and astrocyte-targeted therapies in NMO.

Indexed as

AnimalsAnimals, NewbornAquaporin 4AstrocytesAxonsCells, CulturedCerebrospinal FluidDisease Models, AnimalGlial Fibrillary Acidic ProteinGlutamic AcidHumansImmunoglobulin GMovement DisordersMyelin Basic ProteinMyelin SheathNeuromyelitis OpticaAQP4 protein, humanAquaporin 4Glial Fibrillary Acidic ProteinGlutamic AcidImmunoglobulin GMyelin Basic ProteinAnimal modelAquaporin-4AstrocyteAutoantibodiesAutoimmune diseasesGlutamateNeuromyelitis optica

Identifiers

PMID27193196
PMCPMC4872335
OpenAlexW2397997430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.